Log in or Sign up for Free to view tailored content for your specialty!
Alzheimer’s Disease/Dementia News
Daily napping among older adults linked to a 40% higher risk for Alzheimer’s disease
Older adults who nap for more than an hour a day had a 40% higher risk for developing Alzheimer’s disease compared with those who napped less than an hour a day, researchers reported in Alzheimer’s & Dementia.
Delirium tied to poor HF outcomes in patients discharged to skilled nursing facilities
Delirium, independent of preexisting dementia, at the time of discharge to a skilled nursing facility after HF hospitalization was associated with increased risk for 30-day and 1-year mortality among veterans, researchers reported.
Log in or Sign up for Free to view tailored content for your specialty!
Risk for cognitive decline associated with older COVID-19 survivors
An increased risk for cognitive decline was associated with adults aged 60 years and older, following severe cases of COVID-19, in Wuhan, China, experts reported in JAMA Neurology.
Acadia resubmits sNDA for pimavanserin for Alzheimer’s disease psychosis
Acadia Pharmaceuticals Inc. has resubmitted its supplemental new drug application to the FDA for pimavanserin for treating hallucinations and delusions linked to Alzheimer’s disease psychosis.
Diagnosis of mental disorders linked to higher risk for dementia
Diagnosis of mental disorders was associated with an increased risk for the onset of dementia later in life, according to results of a population-based administrative register study published in JAMA Psychiatry.
Multimorbidity associated with increased risk for dementia
Adults with two or more chronic conditions by middle age had an increased risk for dementia later in life, according to findings published in The BMJ.
Older Americans’ interest in Aduhelm limited despite publicity, FDA approval
Publicity surrounding FDA approval of Aduhelm for Alzheimer’s disease did not contribute to understanding of nor enthusiasm for the drug among middle-aged and older adults, according to survey results published in JAMA Network Open.
AHA: Shared risk factors contribute to rising global burden of brain disease, CVD
Heart disease continues to stand as the leading global cause of death, but there has been a rapid rise in brain disease-related deaths, and risk factors for both are similar, according to an American Heart Association report.
Medicare proposal would limit Aduhelm coverage to those enrolled in clinical trials
CMS has proposed a National Coverage Determination decision memorandum specifying “coverage with evidence development” for FDA-approved monoclonal antibodies targeting amyloid for treating Alzheimer’s disease.
Dementia cases may soar 166% worldwide by 2050
The number of people with dementia worldwide could increase 166%, from about 57.4 million people in 2019 to 152.8 million people in 2050, data from the Global Burden of Diseases, Injuries and Risk Factors Study showed.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read